Bellicum Pharmaceuticals Inc (BLCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 8,936 | 13,512 | 12,303 | 11,758 | 14,619 |
| Operating Income | -8,936 | -13,012 | -12,303 | -11,758 | -14,619 |
| Interest Expense | 4 | 186 | 725 | 763 | 985 |
| Other Income | -2,327 | 31,981 | 12,141 | -30,673 | 33,180 |
| Pre-tax Income | -11,267 | 18,783 | -887 | -43,194 | 17,576 |
| Net Income Continuous | -11,267 | 18,783 | -887 | -43,194 | 17,576 |
| Net Income | $-11,267 | $18,783 | $-887 | $-43,194 | $17,576 |
| EPS Basic Total Ops | -1.12 | 6.30 | -0.18 | -8.55 | 1.09 |
| EPS Basic Continuous Ops | -1.12 | 3.90 | -0.18 | -8.55 | 3.49 |
| EPS Diluted Total Ops | -1.12 | 6.30 | -0.18 | -8.55 | 1.09 |
| EPS Diluted Continuous Ops | -1.12 | 3.90 | -0.18 | -8.55 | 3.49 |
| EBITDA(a) | $-8,889 | $-13,269 | $-11,837 | $-11,196 | $-13,868 |